대명이십일

비상장계속사업자

DaeMyung21 Inc

김명회

Investment Review Report

Auto-filled from disclosures & public data + AI-drafted analysis. Edit, then export to PDF/DOCX.

Editor

1.Deal Terms

2.Valuation / Exit Assumptions

Exit Scenarios100M KRW

3.Fund Eligibility

Fund mandate eligibility — no data, enter manually

Enter fund mandate requirements and applicability (Y/N) to include a table in the report.

4.Capital Changes

Not in DART — enter capital-raise history manually

Enter capital changes such as founding capital and paid-in increases.

5.Stock Options

Enter manually

Enter stock option grant history.

6.Investment Highlights

AI draft — editable

Click 'Generate AI draft' to populate data-grounded investment highlights.

7.Investment Risks

AI draft — editable

Risks are populated after 'Generate AI draft'.

8.Market Analysis

AI draft — editable

9.Business Analysis

AI draft — editable

10.Conclusion (Investment Opinion)

AI draft — editable

11.P&L Projection

Analyst estimates, manual entry (100M KRW). Generates a trend chart & table.

Enter projected revenue / op. profit / net income (100M KRW) by year to add a trend chart and table.
Preview— the document below is saved as PDF/DOCX

Investment Review Report

대명이십일

Business Reg. No. 1178149576 · CEO 김명회

I.Investment Overview

Target대명이십일 (1178149576)
Investment
Post-deal stake
ValuationPre — / Post —

II.Investment Highlights

No investment highlights written yet.

III.Investment Risks

No risks written yet.

IV.Company Profile

회사명대명이십일
영문명DaeMyung21 Inc
대표자김명회
사업자등록번호1178149576
법인등록번호1101112970972
설립일2004.03.12
종업원수14명

V.Workforce

14

Current headcount · 2026.06 as of

VI.Financial Summary

Per DART disclosure · in 억/만원 (KRW)

Financial trend (100M KRW)

매출액100M KRW705.92021480.22022833.72023922.82024767.82025
영업이익100M KRW26.8202124.3202257.9202322.3202482.82025
순이익100M KRW27.8202132.9202254.8202325.7202443.72025
Item20252024202320222021
자산총계795억원846억원658.8억원525.4억원571억원
부채총계353.2억원447.9억원286.4억원207.8억원286.3억원
자본총계441.8억원398.1억원372.4억원317.6억원284.7억원
매출액767.8억원922.8억원833.7억원480.2억원705.9억원
영업이익82.8억원22.3억원57.9억원24.3억원26.8억원
순이익43.7억원25.7억원54.8억원32.9억원27.8억원

VII.Financial Ratios

FY2025 basis

10.78%

영업이익률

5.69%

순이익률

5.49%

ROA

9.88%

ROE

79.95%

부채비율

55.57%

자기자본비율

VIII.Valuation & Exit Plan

Exit valuation
Holding period5y
Enter exit assumptions (investment, stake, exit valuation, period) to see MOIC·IRR.

This report compiles disclosure & public data and AI-drafts some sections as a research aid. It is not investment advice; the user bears final responsibility for facts and investment decisions.

대명이십일 투심보고서 | Alpha Lenz